Valuation: Huntsworth plc

Market Cap 412M 361M 333M 309M 586M 39.34B 594M 3.98B 1.55B 19.31B 1.55B 1.51B 66.96B P/E 2018
17.7x
P/E 2019 15.1x
Enterprise Value 528M 462M 426M 395M 751M 50.35B 761M 5.1B 1.98B 24.72B 1.98B 1.94B 85.69B EV / Sales 2018
2x
EV / Sales 2019 1.57x
Free-Float
-
Yield 2018
2.13%
Yield 2019 3.19%
Manager TitleAgeSince
Compliance Officer 59 01/01/2008
Director TitleAgeSince
Director/Board Member 42 01/10/2019
Director/Board Member - 07/02/2022
Date Insider Type Main position Quantity % Market Cap.
27/03/20Fiscal year

Director

1,472,392 0.3978%
27/03/20Sell

Director

608,059 0.1643%
12/03/20Fiscal year

Director

151,469 0.0409%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 508M
+0.77%-2.00%-4.17%+23.27% 24.53B
+1.63%+8.08%+6.95%-13.29% 22.77B
+3.27%+4.98%-30.49%-25.37% 10.76B
+19.40%-.--%+7,553.85% - 6.83B
+2.29%+6.03%+35.53%+22.97% 5B
+1.11%+14.28%+0.97%+53.58% 4.8B
+19.71%+4.22% - - 3.72B
+2.35%+4.44%-51.05%-68.26% 3.7B
+2.26%+9.11%-15.04%+59.08% 2.98B
Average +5.29%+4.12%+937.07%+7.42% 8.56B
Weighted average by Cap. +3.85%+3.44%+630.11%+3.91%

Financials

2018 2019
Net sales 225M 197M 181M 168M 320M 21.46B 324M 2.17B 845M 10.53B 845M 826M 36.52B 265M 232M 214M 198M 377M 25.26B 382M 2.56B 995M 12.4B 995M 973M 43B
Net income 21.29M 18.65M 17.17M 15.94M 30.27M 2.03B 30.68M 206M 80.01M 997M 79.96M 78.2M 3.46B 20.3M 17.78M 16.37M 15.2M 28.86M 1.94B 29.25M 196M 76.27M 950M 76.22M 74.55M 3.29B
Net Debt 77M 67.44M 62.11M 57.66M 109M 7.35B 111M 744M 289M 3.61B 289M 283M 12.5B 115M 101M 93.11M 86.42M 164M 11.01B 166M 1.11B 434M 5.4B 433M 424M 18.74B
Logo Huntsworth plc
Huntsworth Limited is a United Kingdom-based intermediate holding company. The Company is engaged in healthcare and communication activities. The Company, through its subsidiaries, is focused on health that provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceuticals and biotechnology companies. It also provides a range of communications and advisory services, including strategic communications, public affairs, investor relations and consumer marketing. The Company’s financial instruments comprise bank loans, bank overdrafts, loan notes, and cash and short-term deposits. The Company’s geographical areas include the United Kingdom, Europe, the United States and the rest of the world. The Company’s subsidiaries operate in approximately 28 in the United Kingdom and Europe.
Employees
-